Troubleshooting PCA Plots in RNA-seq: Why Do My Samples Not Cluster as Expected?

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-20

Key Takeaways

• Unexpected PCA clustering often stems from technical artifacts like batch effects or sample outliers, necessitating inspection of raw read counts, mapping rates, and gene body coverage for individual samples.
• Batch effects, where samples cluster by sequencing run or library preparation date rather than biological condition, can be identified by adding batch information to metadata and examining PC loadings for batch-associated genes.
• High biological variability or weak treatment effects can lead to scattered biological replicates; evaluate the proportion of variance explained by each PC and the dispersion of housekeeping genes to assess signal strength.
• A dominant technical or biological factor driving PC1 can mask experimental condition effects, requiring identification of genes with high PC1 loadings to assess if they correspond to known technical artifacts or unrecorded biological variables.
• Normalization failures or excessive technical noise can prevent expected separation; re-running normalization with alternative methods (e.g., TMM, median-of-ratios) and assessing library size distributions are crucial diagnostic steps.
• Hidden biological variables such as sex or cell type composition can create unexpected clusters; examine known marker genes and compare sample metadata for unrecorded variables to identify these drivers.

Principal component analysis (PCA) is a dimensionality reduction technique that projects high-dimensional gene expression data into a smaller number of components that capture the largest sources of variation in the dataset. In RNA-seq analysis, PCA plots are routinely used as an initial quality assessment to determine whether biological replicates group together and whether distinct experimental conditions separate from one another. When samples fail to cluster as expected, the cause may be biological variation, batch effects, technical artifacts, or a combination of these factors. This article provides a systematic diagnostic framework for interpreting unexpected PCA clustering patterns, with concrete steps for data inspection, quality control, re-normalization, and documentation. The guidance applies to researchers working with bulk RNA-seq data, including those using count-based workflows, alignment-free quantification methods, and long-read sequencing platforms.

At a Glance: Common PCA Clustering Problems and Initial Diagnostic Steps

The table below summarizes the most frequently observed PCA clustering issues, their likely causes, and the first diagnostic action to take. Use this table as a starting point before proceeding to the detailed troubleshooting sections.

Understanding What PCA Does and Does Not Show

PCA reduces the dimensionality of a gene expression matrix by identifying orthogonal axes, called principal components, that capture decreasing amounts of variance across the dataset. The first principal component (PC1) captures the largest source of variation, PC2 captures the second largest, and so on. When you plot PC1 against PC2, you see a two-dimensional projection of the samples based on the genes that contribute most strongly to the variation along those axes.

PCA does not perform clustering. It does not assign samples to groups or test whether groups are statistically different. The visual separation of samples in a PCA plot reflects the structure of the data as defined by the genes with the highest loadings on the plotted components. A sample that appears isolated may be separated because of a single gene with extreme expression, a small set of genes with coordinated changes, or a global shift in expression levels across many genes.

The proportion of variance explained by each principal component is a critical piece of information that is often overlooked. If PC1 explains only 8 percent of the variance and PC2 explains 6 percent, the plot shows a small fraction of the total variation in the dataset. In such cases, the absence of clear clustering may simply mean that the biological signal is distributed across many genes and many components, instead of concentrated in the first two. Conversely, if PC1 explains 60 percent of the variance and separates samples by sequencing date instead of condition, a dominant technical effect is present.

RNA-seq quantifies the abundance of transcripts within a biological sample and performs differential analysis between different conditions to reveal regulated gene signatures [<a href="#ref-1">1</a>]. The analytical workflow from raw reads to a PCA plot involves multiple decision points, each of which can influence the final clustering pattern. These include read alignment or quantification method, gene-level summarization, normalization approach, filtering criteria, and the choice of transformation applied before PCA.

Data Inputs That Influence PCA Results

Raw Count Matrix and Gene Annotations

The starting point for PCA is a count matrix with genes in rows and samples in columns. The quality of this matrix depends on the accuracy of read alignment or quantification and the completeness of gene annotations. Incomplete annotations can cause reads to be assigned to incorrect genes or discarded entirely, which reduces the effective signal available for PCA.

For alignment-based workflows, reads are mapped to a reference genome or transcriptome using a splice-aware aligner. The resulting alignments are summarized to gene-level counts using annotation files that define the genomic coordinates of exons and transcripts. Errors in the annotation file, such as overlapping gene models or missing isoforms, can lead to ambiguous read assignments that introduce noise into the count matrix.

Alignment-free methods quantify transcript abundance directly from raw reads without a separate alignment step. These methods are computationally efficient and are well suited for datasets with a reference transcriptome. However, they are sensitive to the completeness and accuracy of the transcript reference, and they may handle multi-mapping reads differently than alignment-based methods.

Long-read sequencing platforms offer real-time sequencing opportunities, providing rapid access to sequenced data and allowing researchers to manage the sequencing process efficiently [<a href="#ref-2">2</a>]. Real-time quality control measures can assess sample and condition variability and determine the number of identified genes per sample and condition [<a href="#ref-2">2</a>]. For long-read RNA-seq, PCA can be performed on transcript-level counts instead of gene-level counts, which provides additional resolution but also introduces additional complexity in terms of transcript annotation and quantification.

Metadata Completeness

The metadata file that accompanies the count matrix is as important as the count data itself. PCA can only reveal patterns that correspond to variables recorded in the metadata. If a batch effect is present but the batch variable is not recorded, the clustering pattern will be difficult to interpret. Conversely, if an unrecorded biological variable such as sex, age, or tissue composition drives the separation, the pattern may be mistakenly attributed to the experimental condition.

Before running PCA, verify that the metadata includes all relevant variables: condition, batch, sequencing run, library preparation date, RNA extraction date, animal or patient identifier, sex, age, and any other factor that could plausibly affect gene expression. The absence of a variable does not mean it is irrelevant. It means that you cannot test for its contribution to the observed clustering.

Filtering and Normalization Choices

Lowly expressed genes contribute noise to PCA because their counts are dominated by technical variation. Filtering genes with very low counts across most samples reduces this noise and can improve the separation of biological groups. The filtering threshold should be based on the library sizes and the expected expression levels in the experiment. A common approach is to retain genes with a minimum number of counts in a minimum number of samples, but the specific thresholds depend on the dataset.

Normalization adjusts for differences in library size and composition across samples. The choice of normalization method can substantially affect PCA results. Methods that assume most genes are not differentially expressed, such as trimmed mean of M-values (TMM) or median-of-ratios, are appropriate for datasets where the majority of genes are expected to be stable. Methods that scale by total library size may be inadequate when a small number of highly expressed genes dominate the counts in some samples.

The transformation applied before PCA also matters. PCA is often performed on log-transformed counts or on variance-stabilized data. The log transformation compresses the dynamic range of the data and reduces the influence of extremely high counts. Variance-stabilizing transformations account for the mean-variance relationship in count data and can improve the performance of PCA for downstream visualization.

Core Principles for Diagnosing Unexpected Clustering

Distinguish Biological Variation from Technical Artifacts

Biological variation is the natural difference in gene expression between individual organisms or samples within the same condition. This variation is expected and can be substantial, particularly in studies involving outbred populations, human clinical samples, or complex tissues with variable cell type composition. Technical artifacts arise from the experimental and computational processes: RNA quality differences, library preparation efficiency, sequencing depth variation, batch effects, and alignment or quantification errors.

The distinction between biological and technical variation is not always clear. A sample that separates from its group may do so because of a genuine biological difference, such as a sample collected from a different tissue region or a sample with an undiagnosed condition. The diagnostic process involves ruling out technical causes first, then evaluating whether the biological explanation is plausible given the experimental design.

Examine the Proportion of Variance Explained

The percentage of variance explained by each principal component provides context for interpreting the plot. If PC1 and PC2 together explain less than 20 percent of the total variance, the plot may not reveal the dominant biological signal. In this situation, examine additional principal components to determine whether the expected grouping appears on PC3, PC4, or higher components.

The variance explained by each component can also indicate the presence of a dominant technical effect. If PC1 explains a very high proportion of variance, such as 70 percent or more, and separates samples by batch or sequencing depth, the dataset is likely dominated by a technical artifact that should be addressed before downstream analysis.

Inspect Gene Loadings

The loadings of genes on each principal component identify which genes contribute most strongly to the separation of samples along that component. Examining the top loading genes can reveal whether the separation is driven by biologically meaningful genes, such as condition-specific markers, or by technical artifacts, such as ribosomal RNA genes, mitochondrial genes, or genes affected by sample degradation.

For example, if PC1 separates samples by the expression of a small set of genes that are known to be affected by RNA integrity, the separation may reflect differences in RNA quality instead of biological condition. If PC1 separates samples by the expression of sex-specific genes, the separation may reflect the sex composition of the samples instead of the experimental condition.

Compare Within-Group and Between-Group Distances

The distance between samples in a PCA plot reflects their similarity in gene expression. Samples from the same condition should be closer to each other than to samples from other conditions, assuming the condition has a biological effect on gene expression. However, the absolute distances depend on the scale of the data and the proportion of variance explained by the plotted components.

A useful diagnostic is to calculate the average pairwise distance between samples within each group and compare it to the average distance between groups. If the within-group distances are as large as the between-group distances, the biological signal is weak relative to the noise. This may indicate that the condition has a small effect, that the sample size is insufficient, or that technical variation is overwhelming the biological signal.

Practical Workflow for Troubleshooting PCA Plots

Step 1: Verify the Input Data

Begin by confirming that the count matrix and metadata are correctly formatted and that sample identifiers match between the two files. A mismatch in sample names is a common cause of apparent clustering problems. Check that the number of samples in the metadata matches the number of columns in the count matrix and that the condition labels are correctly assigned.

Inspect the total number of reads or counts per sample. Samples with very low library sizes may have noisy expression profiles that cause them to separate from the rest of the dataset. Samples with very high library sizes may dominate the normalization and cause other samples to appear compressed. The distribution of library sizes should be relatively uniform across samples within each condition.

Step 2: Assess Sequencing and Alignment Quality

For each sample, examine the standard quality metrics: total read count, percentage of reads mapped to the reference, percentage of reads assigned to genes, and the distribution of reads across gene body positions. Samples with low mapping rates or low gene assignment rates may have technical problems that affect their expression profiles.

Real-time quality control during sequencing can assess sample and condition variability and determine the number of identified genes per sample and condition [<a href="#ref-2">2</a>]. For long-read RNA-seq, this real-time analysis can identify differentially expressed genes as early as one hour after sequencing initiation, and these changes are consistently observed throughout the entire sequencing process [<a href="#ref-2">2</a>]. This capability allows researchers to detect problematic samples early and make decisions about whether to continue sequencing or to resequence specific samples.

Step 3: Examine the Count Distribution

Plot the distribution of counts for each sample using boxplots or density plots. Samples with unusual distributions, such as a high proportion of zero counts or an excess of very high counts, may have technical issues. The shape of the count distribution should be similar across samples within the same condition.

Check for the presence of genes with extremely high counts in a single sample. These genes can dominate the PCA and cause the sample to separate from the rest of the dataset. If such genes are identified, determine whether they are biologically plausible or whether they represent artifacts such as contamination or alignment errors.

Step 4: Re-run PCA with Different Normalization and Transformation Options

The choice of normalization method can change the PCA results. If the initial PCA shows unexpected clustering, re-run the analysis with an alternative normalization method and compare the results. For example, if the initial analysis used a method that assumes most genes are not differentially expressed, try a method that is more robust to differences in library composition.

Similarly, the transformation applied before PCA can affect the results. Try PCA on log-transformed counts, variance-stabilized data, and regularized log-transformed data. Compare the clustering patterns across these transformations to determine whether the unexpected pattern is robust or whether it depends on the specific data processing choices.

Step 5: Investigate Outlier Samples

When a single sample separates from its group, investigate the sample in detail. Check the sequencing quality metrics, the alignment statistics, and the expression of known marker genes. Determine whether the sample has a different cell type composition, whether it was collected from a different tissue region, or whether it has an undiagnosed condition.

If the outlier is a technical artifact, consider whether to exclude the sample from the analysis or to include it with a note in the methods. The decision depends on the cause of the outlier and the impact on the downstream analysis. Excluding a sample reduces the sample size and may affect statistical power. Including a technical outlier may introduce noise and bias into the differential expression analysis.

Step 6: Test for Batch Effects

If samples cluster by sequencing batch, library preparation date, or another technical variable, the dataset has a batch effect. The first step is to confirm that the batch variable is recorded in the metadata. Then, examine whether the batch effect is confounded with the biological condition. If all samples from one condition were processed in one batch and all samples from another condition were processed in a different batch, the batch effect cannot be distinguished from the biological effect.

When batch effects are present and not confounded with the condition, statistical methods can be used to adjust for the batch variable in the differential expression analysis. These methods model the batch effect and remove its contribution to the expression estimates. However, batch correction should be applied carefully, and the corrected data should be examined to ensure that the biological signal is preserved.

Step 7: Consider Hidden Biological Variables

If the PCA reveals clusters that do not correspond to the recorded metadata, consider whether unrecorded biological variables are driving the separation. Sex is a common hidden variable that affects gene expression across many tissues. Age, genetic background, diet, and environmental exposures can also contribute to expression variation.

Examine the expression of known marker genes for the suspected hidden variable. For example, if sex is suspected, check the expression of XIST or Y chromosome genes. If cell type composition is suspected, check the expression of cell type-specific markers. If a hidden variable is identified, add it to the metadata and include it in the downstream analysis model.

Options and Tradeoffs in PCA-Based Quality Assessment

Gene-Level versus Transcript-Level PCA

PCA can be performed on gene-level counts or transcript-level counts. Gene-level counts aggregate reads across all isoforms of a gene, which reduces the complexity of the data and is appropriate for most analyses. Transcript-level counts preserve isoform information and can reveal patterns that are masked at the gene level, such as isoform switching between conditions.

The tradeoff is that transcript-level counts are more variable and more sensitive to annotation errors and quantification uncertainty. If the transcript annotation is incomplete or inaccurate, transcript-level PCA may show spurious clustering patterns. For initial quality assessment, gene-level PCA is generally more robust.

Count-Based versus Alignment-Free Quantification

Alignment-based quantification methods map reads to a reference genome and then summarize the alignments to gene-level counts. These methods provide detailed information about read placement and can handle complex splicing patterns. Alignment-free methods quantify transcript abundance directly from raw reads, which is computationally faster but provides less information about read placement.

The choice between these approaches can affect PCA results. Alignment-free methods may handle multi-mapping reads differently, which can influence the expression estimates for genes with high sequence similarity. If the PCA shows unexpected clustering, consider whether the quantification method is appropriate for the data and whether an alternative method produces different results.

Fixed Reference versus Reference-Free Analysis

Most RNA-seq analyses use a fixed reference genome or transcriptome for quantification. This approach is appropriate when a high-quality reference is available for the species being studied. Reference-free analysis, which assembles transcripts without a reference, is used for non-model organisms or when the reference is incomplete.

Reference-free analysis is more computationally intensive and produces results that are more difficult to compare across studies. The PCA results from reference-free analysis may be influenced by assembly errors and by the completeness of the transcriptome reconstruction. If the reference is incomplete, some genes may be missing from the count matrix, which reduces the biological signal available for PCA.

Real-Time Analysis for Long-Read Sequencing

Long-read sequencing platforms offer the possibility of real-time analysis, where quality control and differential expression analysis are performed while the sequencing run is in progress [<a href="#ref-2">2</a>]. This approach allows researchers to detect problems early and to make decisions about whether to continue sequencing or to adjust the experimental plan.

Real-time analysis can assess sample and condition variability and determine the number of identified genes per sample and condition [<a href="#ref-2">2</a>]. This information can be used to determine whether the sequencing depth is sufficient to detect the expected biological differences and whether additional sequencing is needed. The tradeoff is that real-time analysis requires additional computational resources and may not be necessary for all experiments.

Observations and Measurements for PCA Troubleshooting

Metrics to Record for Each Sample

Maintain a record of the following metrics for each sample in the experiment. These measurements are used to diagnose clustering problems and to document the quality of the dataset.

Recording PCA Results

For each PCA run, record the following information: the normalization method, the transformation applied, the filtering criteria, the number of genes included, the proportion of variance explained by each of the first several principal components, and the sample coordinates on the plotted components. This documentation allows you to reproduce the analysis and to compare results across different data processing choices.

When a clustering problem is identified, record the diagnostic steps taken and the conclusions reached. This documentation is valuable for the methods section of a publication and for future reference when analyzing similar datasets.

Using Control Samples

Control samples, such as technical replicates or spike-in controls, provide a baseline for assessing technical variation. If control samples cluster together in the PCA, the technical variation is relatively small. If control samples are scattered, the technical variation is large and may be contributing to the unexpected clustering of biological samples.

Spike-in controls, such as external RNA controls, can be used to assess the accuracy of quantification and normalization. The expected concentrations of the spike-in controls are known, so the measured concentrations can be compared to the expected values to identify systematic biases.

Common Failure Patterns in PCA Troubleshooting

Failure to Check Metadata for Errors

A common mistake is to assume that the metadata is correct without verification. Sample labels can be swapped, condition assignments can be incorrect, and batch variables can be missing or misrecorded. These errors can produce PCA patterns that are difficult to interpret and that lead to incorrect conclusions.

The diagnostic process should begin with a careful review of the metadata. Verify that the sample identifiers match between the count matrix and the metadata, that the condition labels are correct, and that all relevant technical variables are recorded.

Overinterpreting Small Differences in PCA Plots

PCA plots are visualizations, and small differences in the positions of samples may not be meaningful. The distance between samples in a PCA plot depends on the scale of the data and the proportion of variance explained by the plotted components. Two samples that appear close together may have substantially different expression profiles if the plotted components capture only a small fraction of the total variance.

Before concluding that samples do not cluster as expected, examine the proportion of variance explained by the plotted components and consider whether the visual pattern is consistent with the biological expectations. A lack of clear separation may simply reflect the fact that the biological signal is distributed across many genes and many components.

Ignoring the Influence of Highly Expressed Genes

A small number of highly expressed genes can dominate the PCA and cause samples to separate based on the expression of these genes instead of on the overall biological differences. This is particularly problematic when the highly expressed genes are not related to the experimental condition.

To diagnose this problem, examine the top loading genes on the principal components and determine whether they are biologically relevant. If the top loading genes are housekeeping genes, ribosomal genes, or genes affected by technical artifacts, consider filtering these genes or using a transformation that reduces their influence.

Applying Batch Correction Without Justification

Batch correction methods can remove technical variation from the data, but they can also remove biological variation if the batch variable is confounded with the condition. Applying batch correction without justification can produce misleading results and can make it difficult to interpret the biological findings.

Batch correction should be applied only when there is evidence of a batch effect and when the batch variable is not confounded with the biological condition. The corrected data should be examined to ensure that the biological signal is preserved and that the correction did not introduce artifacts.

Using PCA as a Substitute for Statistical Testing

PCA is a visualization tool, not a statistical test. The visual separation of samples in a PCA plot does not demonstrate that the conditions are statistically different. Conversely, the absence of visual separation does not demonstrate that the conditions are the same.

Differential expression analysis should be used to test for statistically significant differences between conditions. PCA can be used to identify potential problems and to generate hypotheses, but it should not be used as the sole basis for conclusions about biological differences.

Limitations of PCA for RNA-seq Quality Assessment

PCA Captures Only Linear Relationships

PCA is a linear method that identifies orthogonal axes of maximum variance. It cannot capture nonlinear relationships in the data. If the biological differences between conditions involve nonlinear changes in gene expression, PCA may not reveal the expected separation.

Nonlinear dimensionality reduction methods, such as t-distributed stochastic neighbor embedding (t-SNE) or uniform manifold approximation and projection (UMAP), can capture nonlinear structure in the data. However, these methods have their own limitations, including sensitivity to hyperparameters and difficulty in interpreting the resulting plots.

PCA Is Sensitive to Scaling and Transformation

The results of PCA depend on the scaling and transformation of the data. Different transformations can produce different clustering patterns, and the choice of transformation is not always obvious. The log transformation is commonly used, but it can be sensitive to the pseudocount added to avoid the logarithm of zero.

Variance-stabilizing transformations account for the mean-variance relationship in count data and may produce more reliable PCA results. However, these transformations make assumptions about the data that may not hold for all datasets.

PCA Does Not Identify the Cause of Separation

PCA identifies the axes of maximum variance and the genes that contribute to those axes, but it does not identify the cause of the separation. The interpretation of the PCA plot requires biological knowledge and additional analyses. A separation along PC1 may be caused by a batch effect, a biological difference, or a combination of factors, and PCA alone cannot distinguish between these possibilities.

PCA Results Depend on the Genes Included

The set of genes included in the PCA affects the results. Filtering lowly expressed genes removes noise but may also remove biologically relevant genes. Including all genes may allow technical noise to dominate the analysis. The choice of filtering criteria should be documented and justified.

PCA Cannot Detect All Technical Artifacts

Some technical artifacts do not produce obvious patterns in PCA plots. For example, a subtle degradation of RNA that affects a small number of genes may not cause samples to separate in the PCA, even though it affects the differential expression analysis. PCA should be used in combination with other quality control measures, not as a substitute for them.

Quality and Welfare Context for PCA Troubleshooting

Sample Quality and RNA Integrity

The quality of the input RNA is a major determinant of the quality of the RNA-seq data. Degraded RNA produces expression profiles that are biased toward the 3' end of transcripts and that may not accurately reflect the biological state of the sample. Samples with degraded RNA may separate from samples with intact RNA in the PCA, even when the biological condition is the same.

RNA integrity should be assessed before library preparation, and samples with low integrity should be flagged. If a sample with low RNA integrity separates from its group in the PCA, the separation is likely due to RNA quality instead of biological differences.

Ethical and Regulatory Considerations for Sample Collection

The collection of biological samples for RNA-seq must follow ethical and regulatory guidelines. For human samples, informed consent is required, and the study must be approved by an institutional review board. For animal samples, the study must be approved by an institutional animal care and use committee, and the animals must be housed and handled according to established welfare standards.

The metadata should include information about the ethical approval and the sample collection procedures. This information is important for interpreting the PCA results and for documenting the study in publications.

Data Sharing and Reproducibility

RNA-seq data should be deposited in public databases, such as those maintained by the National Center for Biotechnology Information (NCBI), to allow other researchers to reproduce the analysis and to verify the findings [<a href="#ref-3">3</a>]. The NCBI provides access to sequence data, gene expression data, and other genomic resources [<a href="#ref-3">3</a>].

Reproducibility requires that the analysis workflow is documented in sufficient detail to allow another researcher to repeat the analysis. This documentation should include the software versions, the parameters used, and the data processing steps. Workflow management systems and containerized pipelines can improve reproducibility by standardizing the analysis environment [<a href="#ref-4">4</a>].

Training in bioinformatics methods is available from multiple sources. The European Bioinformatics Institute provides training in data resources and practical analysis education [<a href="#ref-5">5</a>]. The Galaxy Training Network offers accessible workflow training and analysis tutorials [<a href="#ref-6">6</a>]. The Carpentries provides foundational computing and data skills training [<a href="#ref-7">7</a>]. Bioconductor provides official package, workflow, installation, and reproducible genomic-analysis documentation [<a href="#ref-8">8</a>].

Professional Escalation Criteria for PCA Troubleshooting

When to Seek Expert Assistance

Some PCA clustering problems require specialized expertise to resolve. Consider seeking assistance from a bioinformatics core facility, a collaborator with experience in RNA-seq analysis, or a statistical geneticist in the following situations:

• The PCA shows a complex pattern that cannot be explained by the recorded metadata or by known biological variables
• The dataset has multiple potential batch effects that are confounded with the biological condition
• The samples include multiple tissues, cell types, or species, and the expected clustering pattern is unclear
• The differential expression analysis produces results that are inconsistent with the PCA pattern
• The study involves a non-model organism with an incomplete reference genome or transcriptome

When to Consider Redoing the Experiment

In some cases, the PCA reveals problems that cannot be fixed by computational methods. If the RNA quality is poor for many samples, if the library preparation failed for a subset of samples, or if the sequencing depth is insufficient for the biological question, the experiment may need to be repeated.

The decision to redo the experiment should be based on the cost of repeating the experiment, the impact of the problematic samples on the downstream analysis, and the feasibility of collecting new samples. In some cases, excluding the problematic samples and proceeding with the remaining samples is the most practical option.

When to Reconsider the Experimental Design

If the PCA consistently shows no separation between conditions that are expected to differ, the experimental design may be inadequate. The sample size may be too small to detect the biological effect, the conditions may not be sufficiently different, or the tissue or cell type may not be the most informative for the biological question.

Reconsidering the experimental design is a significant decision that should be made in consultation with collaborators and with a statistician. The PCA results should be interpreted in the context of the biological question and the existing literature on the topic.

Frequently Asked Questions

Why do my biological replicates not cluster together in the PCA plot?

Biological replicates may not cluster together because of high biological variability, technical variation, or a combination of both. Check the sequencing quality metrics for each sample, including total read count, mapping rate, and gene assignment rate. Examine the proportion of variance explained by the plotted principal components. If PC1 and PC2 explain a small fraction of the total variance, the biological signal may be distributed across many components. Consider whether the samples were collected from different individuals, different tissue regions, or at different times, and whether these factors could contribute to the observed variation.

What should I do if one sample is an obvious outlier in the PCA plot?

Investigate the outlier sample in detail before deciding whether to exclude it. Check the sequencing quality metrics, the alignment statistics, and the expression of known marker genes. Determine whether the sample has a different cell type composition, whether it was collected from a different tissue region, or whether it has an undiagnosed condition. If the outlier is a technical artifact, consider whether to exclude the sample or to include it with a note in the methods. The decision depends on the cause of the outlier and the impact on the downstream analysis.

How can I tell if the separation in my PCA plot is due to a batch effect?

If samples cluster by sequencing batch, library preparation date, or another technical variable, the dataset has a batch effect. Confirm that the batch variable is recorded in the metadata and examine whether the batch effect is confounded with the biological condition. If all samples from one condition were processed in one batch and all samples from another condition were processed in a different batch, the batch effect cannot be distinguished from the biological effect. When batch effects are present and not confounded with the condition, statistical methods can be used to adjust for the batch variable in the differential expression analysis.

What does it mean if my samples separate along PC2 instead of PC1?

If samples separate along PC2 instead of PC1, a dominant factor drives PC1 and masks the condition effect. Identify the genes with high loadings on PC1 and determine whether they correspond to known technical artifacts, such as ribosomal genes, mitochondrial genes, or genes affected by sample degradation. The dominant factor on PC1 may be a batch effect, a difference in RNA quality, or a biological variable that is not the experimental condition. Examine the proportion of variance explained by PC1 and PC2 to understand the relative contribution of each component.

Should I use gene-level or transcript-level counts for PCA?

Gene-level counts are generally more robust for initial quality assessment because they aggregate reads across all isoforms of a gene, which reduces the complexity of the data. Transcript-level counts preserve isoform information and can reveal patterns that are masked at the gene level, but they are more variable and more sensitive to annotation errors and quantification uncertainty. If the transcript annotation is incomplete or inaccurate, transcript-level PCA may show spurious clustering patterns.

How does the choice of normalization method affect PCA results?

The choice of normalization method can substantially affect PCA results. Methods that assume most genes are not differentially expressed, such as trimmed mean of M-values or median-of-ratios, are appropriate for datasets where the majority of genes are expected to be stable. Methods that scale by total library size may be inadequate when a small number of highly expressed genes dominate the counts in some samples. If the initial PCA shows unexpected clustering, re-run the analysis with an alternative normalization method and compare the results.

Can PCA be used to identify hidden biological variables?

PCA can reveal clustering patterns that do not correspond to the recorded metadata, which may indicate the presence of hidden biological variables. Sex is a common hidden variable that affects gene expression across many tissues. Age, genetic background, diet, and environmental exposures can also contribute to expression variation. Examine the expression of known marker genes for the suspected hidden variable. If a hidden variable is identified, add it to the metadata and include it in the downstream analysis model.

What should I do if the PCA shows no separation between conditions that are expected to differ?

If the PCA consistently shows no separation between conditions that are expected to differ, the experimental design may be inadequate. The sample size may be too small to detect the biological effect, the conditions may not be sufficiently different, or the tissue or cell type may not be the most informative for the biological question. Check the proportion of variance explained by the plotted components and consider whether the biological signal is distributed across many components. Reconsider the experimental design in consultation with collaborators and with a statistician.

Related Bioinformatics Guides

• RNA-Seq Visualization: Volcano Plots, Heatmaps, and PCA
• RNA-Seq Batch Effect Detection and Correction
• RNA-Seq vs qPCR: Validation and Comparison
• RNA-Seq vs DNA-Seq: Key Differences and Applications
• RNA-Seq Alignment: Choosing the Right Tool and Parameters

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.